PMA device
Abre Venous Self-expanding Stent System
Medtronic Vascular, Inc. · Stent, Iliac Vein (QAN, Class III) · First FDA decision Oct 21, 2020, newest Jul 22, 2022Pulmonary embolism and deep vein thrombosisVaricose veins and venous insufficiency
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
1
Naming "Abre Venous Self-expanding"
MAUDE reports
315
Brand "Abre Venous Self-expanding", since 2015
PubMed studies
2
Mentioning "Abre Venous Self-expanding"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Abre Venous Self-expanding Stent System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Abre Venous Self-expanding Stent SystemPMA supplement
P200026-S005 · Decided Jul 22, 2022 · 35 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, iliac vein (QAN) · Cardiology
P200026 · Decided Oct 21, 2020 · 177 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Abre Venous Self-expanding", any status and sponsor, newest update first.
Medtronic EndovascularPublic (MDT)
NCT03038438 · 260 participants · Start Dec 13, 2017 · Primary completion Jan 14, 2020
Device: Abre venous self-expanding stent system · For: Iliofemoral Venous Obstruction
Sites: Orange, California; Darien, Connecticut; Atlanta, Georgia · 24 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Abre Venous Self-expanding", and for the whole product code for context.
This brand
315 reports: 108 malfunction, 202 injury, 5 death
Whole product code QAN
1,334 reports: 763 malfunction, 563 injury, 8 death
Newest reports for this brand
2183870-2026-00531 · Received Oct 28, 2026 · Event dated May 18, 2026
Device type: Stent, Iliac Vein (QAN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Restenosis
2183870-2026-00532 · Received Oct 28, 2026 · Event dated May 18, 2026
Device type: Stent, Iliac Vein (QAN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Restenosis
2183870-2026-00533 · Received Oct 28, 2026 · Event dated May 18, 2026
Device type: Stent, Iliac Vein (QAN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Restenosis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1098-2026 · Started Dec 4, 2025 · Posted by FDA Jan 15, 2026
Reason given: Stents may be impacted by a Nitinol anomaly which causes a reduced stent diameter when deployed and corresponding reduced radial force. Issue may result in stent migration.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stent, Iliac Vein (QAN)
- Instructions for Use for all model numbers of the Medtronic Abre Venous Self-Expanding Stent System.Terminated
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-0464-2022 · Started Nov 19, 2021
Reason given: There have been reports of stent migration.
Cause as FDA categorized it: Other · Device type: Stent, Iliac Vein (QAN)
Z-1532-2021 · Started Mar 16, 2021
Reason given: Incorrect size printed on the device; packaging is labeled correctly.
Cause as FDA categorized it: Process control · Device type: Stent, Iliac Vein (QAN)
Published research
The most relevant PubMed records for "Abre Venous Self-expanding"[tiab]. The summary above synthesizes these.
- Three-Year Outcomes of the Abre Venous Self-Expanding Stent System in Patients with Symptomatic Iliofemoral Venous Outflow Obstruction.
Black S, Sapoval M, Dexter DJ, et al. · J Vasc Interv Radiol · 2024Multicenter Study, Observational Study
- Pivotal Study Evaluating the Safety and Effectiveness of the Abre Venous Self-Expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction.
Murphy E, Gibson K, Sapoval M, et al. · Circ Cardiovasc Interv · 2022Multicenter Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code QAN.
- VICI VENOUS STENT SystemBoston Scientific Corporation · PMA 2021
- Duo Venous Stent SystemPhilips Image Guided Therapy Corporation · PMA 2026
- Zilver Vena Venous Self-Expanding StentCook Ireland, Ltd. · PMA 2024
- Venovo Venous Stent SystemBard Peripheral Vascular, Inc. · PMA 2021
- Venous WallstentBoston Scientific Corporation · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.